Medicare Enrolled
Dr. Eleonora Spokoyny, MD
Neurology · Mission Viejo, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Spokoyny from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spokoyny?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Spokoyny
Dr. Eleonora Spokoyny is a neurology specialist in Mission Viejo, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Spokoyny performed 57,119 Medicare services across 723 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spokoyny received a total of $15,049 from 65 pharmaceutical and/or device companies across 626 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spokoyny is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$15,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗57,119
Medicare services
Top 1% in CA for neurology
723
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,856 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
55,080 | $5 | $10 |
| Manual therapy (hands-on treatment), per 15 min | 615 | $18 | $55 |
| Neuromuscular re-education therapy, per 15 min A therapy procedure designed to re-educate the functional connection between the brain, nerves, and muscles. It is billed in 15-minute increments. |
202 | $23 | $30 |
| Electrical stimulation therapy, per 15 minutes Application of electrical stimulation to the body with a therapist present. The service is billed for each 15-minute increment of treatment. |
197 | $10 | $30 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 180 | $71 | $200 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
153 | $176 | $250 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
138 | $88 | $325 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
121 | $154 | $250 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
90 | $392 | $650 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $107 | $225 |
| New patient office visit, complex (60-74 min) | 76 | $183 | $350 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
69 | $253 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $74 | $175 |
| Additional hour of neuropsychological test evaluation This code covers the evaluation of neuropsychological testing for each additional hour beyond the initial service. It represents the time spent analyzing and interpreting test results. |
23 | $84 | $250 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
21 | $27 | $93 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
16 | $110 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,049
Total received (2018-2024)
Avg $2,150/year across 7 years
Top 19% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
626
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,471 (96.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$498 (3.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$79 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,875
2023
$2,481
2022
$1,790
2021
$2,703
2020
$779
2019
$3,117
2018
$1,305
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$823
ABBVIE INC.
$422
Takeda Pharmaceuticals U.S.A., Inc.
$243
ARGENX US, INC.
$219
PFIZER INC.
$166
SK Life Science, Inc.
$161
CSL Behring
$129
Alnylam Pharmaceuticals Inc.
$98
EMD Serono, Inc.
$88
Novartis Pharmaceuticals Corporation
$62
Lilly USA, LLC
$62
Alexion Pharmaceuticals, Inc.
$43
Teva Pharmaceuticals USA, Inc.
$43
Lundbeck LLC
$41
SCILEX PHARMACEUTICALS INC.
$37
Merz Pharmaceuticals, LLC
$36
JAZZ PHARMACEUTICALS INC.
$34
Amneal Pharmaceuticals LLC
$30
Amgen Inc.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Biogen, Inc.
$17
AstraZeneca Pharmaceuticals LP
$17
BANNER LIFE SCIENCES, LLC
$17
IDORSIA PHARMACEUTICALS US INC
$15
Abbott Laboratories
$14
Neurocrine Biosciences, Inc.
$13
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,283
UCB, Inc.
$1,133
Biogen, Inc.
$950
Alexion Pharmaceuticals, Inc.
$880
Amgen Inc.
$861
ABBVIE INC.
$705
ARGENX US, INC.
$647
Alnylam Pharmaceuticals Inc.
$607
SK Life Science, Inc.
$531
Allergan, Inc.
$524
Neurocrine Biosciences, Inc.
$521
AbbVie Inc.
$476
Takeda Pharmaceuticals U.S.A., Inc.
$409
Novartis Pharmaceuticals Corporation
$351
CSL Behring
$309
Avanir Pharmaceuticals, Inc.
$308
Lilly USA, LLC
$303
Janssen Pharmaceuticals, Inc
$257
PFIZER INC.
$254
Sunovion Pharmaceuticals Inc.
$245
JAZZ PHARMACEUTICALS INC.
$230
Genentech USA, Inc.
$226
Octapharma USA, Inc.
$222
Allergan Inc.
$197
Harmony Biosciences LLC
$194
Biohaven Pharmaceuticals, Inc.
$191
Amneal Pharmaceuticals LLC
$155
Akcea Therapeutics, Inc.
$154
Greenwich Biosciences, Inc.
$152
EMD Serono, Inc.
$143
Teva Pharmaceuticals USA, Inc.
$121
Kyowa Kirin, Inc.
$95
SANOFI-AVENTIS U.S. LLC
$90
Merz Pharmaceuticals, LLC
$83
BANNER LIFE SCIENCES, LLC
$80
Almatica Pharma LLC
$72
SCILEX PHARMACEUTICALS INC.
$70
Upsher-Smith Laboratories LLC
$70
Supernus Pharmaceuticals, Inc.
$66
AQUESTIVE THERAPEUTICS, INC.
$63
Eisai Inc.
$61
GENZYME CORPORATION
$56
Amylyx Pharmaceuticals, Inc.
$55
ACADIA Pharmaceuticals Inc
$52
Grifols USA, LLC
$52
Otsuka America Pharmaceutical, Inc.
$51
AstraZeneca Pharmaceuticals LP
$44
Celgene Corporation
$44
Banner Life Sciences, LLC
$41
Lundbeck LLC
$41
Adamas Pharmaceuticals, Inc.
$37
IMPEL PHARMACEUTICALS INC.
$32
HARMONY BIOSCIENCES LLC
$32
Zyla Life Sciences, Inc.
$32
EISAI INC.
$25
Janssen Biotech, Inc.
$23
MERZ NORTH AMERICA, INC.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Zyla Life Sciences
$18
Egalet US Inc
$16
IDORSIA PHARMACEUTICALS US INC
$15
Abbott Laboratories
$14
Azurity Pharmaceuticals, Inc.
$14
Zogenix Inc.
$13
Boston Scientific Corporation
$12
Top 3 companies account for 22.4% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · DUOPA · EMGALITY · Epidiolex · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · HYQVIA · Hizentra · Horizant · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · MAVENCLAD · MAYZENT · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · PANZYGA · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RELYVRIO · REMICADE · RYTARY · Repatha · Rystiggo · SOLIQUA · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · Wakix · XCOPRI · XEOMIN · XYWAV · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
194
Per 100K population
6.1
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Spokoyny is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Spokoyny experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Spokoyny performed 55,080 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spokoyny receive payments from pharmaceutical companies?
Yes. Dr. Spokoyny received a total of $15,049 from 65 companies across 626 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spokoyny's costs compare to other neurologists in Mission Viejo?
Dr. Spokoyny's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spokoyny) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Mission Viejo
Browse neurologists in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology